Post by Biogen on X
Biogen@biogen
X#News: We’re attending the @alzassociation’s International Conference (#AAIC26) to share new data from our Alzheimer’s disease portfolio—including initial data from the Phase 2 study of our investigational tau-targeting therapy. Learn more: t.co
9 likes0 repliesPosted Jun 29, 2026